{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:55:39Z","timestamp":1792036539393,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The poor prognosis of glioblastoma (GBM) patients is attributed mainly to abundant neovascularization and presence of glioblastoma stem cells (GSCs). GSCs are preferentially localized to the perivascular niche to maintain stemness. However, the effect of abnormal communication between endothelial cells (ECs) and GSCs on GBM progression remains unknown. Here, we reveal that ECs-derived SEMA3G, which is aberrantly expressed in GBM patients, impairs GSCs by inducing c-Myc degradation. SEMA3G activates NRP2\/PLXNA1 in a paracrine manner, subsequently inducing the inactivation of Cdc42 and dissociation of Cdc42 and WWP2 in GSCs. Once released, WWP2 interacts with c-Myc and mediates c-Myc degradation via ubiquitination. Genetic deletion of\n                    <jats:italic>Sema3G<\/jats:italic>\n                    in ECs accelerates GBM growth, whereas\n                    <jats:italic>SEMA3G<\/jats:italic>\n                    overexpression or recombinant SEMA3G protein prolongs the survival of GBM bearing mice. These findings illustrate that ECs play an intrinsic inhibitory role in GSCs stemness via the SMEA3G-c-Myc distal regulation paradigm. Targeting SEMA3G signaling may have promising therapeutic benefits for GBM patients.\n                  <\/jats:p>","DOI":"10.1038\/s41418-025-01534-3","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:01:42Z","timestamp":1750230102000},"page":"2340-2354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Endothelial cells-derived SEMA3G suppresses glioblastoma stem cells by inducing c-Myc degradation"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-7252","authenticated-orcid":false,"given":"Peng-Xiang","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-1295","authenticated-orcid":false,"given":"Li-Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9781-6281","authenticated-orcid":false,"given":"Yi-Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1533-8568","authenticated-orcid":false,"given":"Xu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Horimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3187-4344","authenticated-orcid":false,"given":"Ying-Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-3491","authenticated-orcid":false,"given":"Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"1534_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329:574\u201387.","journal-title":"JAMA"},{"key":"1534_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrc2246","volume":"7","author":"RJ Gilbertson","year":"2007","unstructured":"Gilbertson RJ, Rich JN. Making a tumour\u2019s bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007;7:733\u20136.","journal-title":"Nat Rev Cancer"},{"key":"1534_CR3","doi-asserted-by":"crossref","unstructured":"Testa E, Palazzo C, Mastrantonio R, Viscomi MT. Dynamic interactions between tumor cells and brain microvascular endothelial cells in glioblastoma. Cancers. 2022;14:3128.","DOI":"10.3390\/cancers14133128"},{"key":"1534_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Ther. 2024;9:149.","journal-title":"Signal Transduct Target Ther"},{"key":"1534_CR5","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.ajpath.2012.06.030","volume":"181","author":"ME Hardee","year":"2012","unstructured":"Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol. 2012;181:1126\u201341.","journal-title":"Am J Pathol"},{"key":"1534_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/neuonc\/noaa297","volume":"23","author":"JC Carlson","year":"2021","unstructured":"Carlson JC, Cantu Gutierrez M, Lozzi B, Huang-Hobbs E, Turner WD, Tepe B, et al. Identification of diverse tumor endothelial cell populations in malignant glioma. Neuro-Oncol. 2021;23:932\u201344.","journal-title":"Neuro-Oncol"},{"key":"1534_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","volume":"30","author":"CE Brown","year":"2024","unstructured":"Brown CE, Hibbard JC, Alizadeh D, Blanchard MS, Natri HM, Wang D, et al. Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. Nat Med. 2024;30:1001\u201312.","journal-title":"Nat Med"},{"key":"1534_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43743-9","volume":"15","author":"H Lv","year":"2024","unstructured":"Lv H, Zong Q, Chen C, Lv G, Xiang W, Xing F, et al. TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer. Nat Commun. 2024;15:6.","journal-title":"Nat Commun"},{"key":"1534_CR9","doi-asserted-by":"publisher","first-page":"eabm4459","DOI":"10.1126\/science.abm4459","volume":"375","author":"M Martin","year":"2022","unstructured":"Martin M, Vermeiren S, Bostaille N, Eubelen M, Spitzer D, Vermeersch M, et al. Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders. Science. 2022;375:eabm4459.","journal-title":"Science"},{"key":"1534_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396\u2013401.","journal-title":"Nature"},{"key":"1534_CR11","doi-asserted-by":"publisher","first-page":"108673","DOI":"10.1016\/j.pharmthera.2024.108673","volume":"260","author":"K Peterson","year":"2024","unstructured":"Peterson K, Turos-Cabal M, Salvador AD, Palomo-Caturla I, Howell AJ, Vieira ME, et al. Mechanistic insights into medulloblastoma relapse. Pharm Ther. 2024;260:108673.","journal-title":"Pharm Ther"},{"key":"1534_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.conb.2017.06.008","volume":"47","author":"LJ Brooks","year":"2017","unstructured":"Brooks LJ, Parrinello S. Vascular regulation of glioma stem-like cells: a balancing act. Curr Opin Neurobiol. 2017;47:8\u201315.","journal-title":"Curr Opin Neurobiol"},{"key":"1534_CR13","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","volume":"56","author":"A Sattiraju","year":"2023","unstructured":"Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity. 2023;56:1825\u201343.","journal-title":"Immunity"},{"key":"1534_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","volume":"1","author":"D Hambardzumyan","year":"2015","unstructured":"Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends cancer. 2015;1:252\u201365.","journal-title":"Trends cancer"},{"key":"1534_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3171\/2008.4.17492","volume":"110","author":"A Narayana","year":"2009","unstructured":"Narayana A, Kelly P, Golfinos J, Parker E, Johnson G, Knopp E, et al. Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival. J Neurosurg. 2009;110:173\u201380.","journal-title":"J Neurosurg"},{"key":"1534_CR16","doi-asserted-by":"publisher","first-page":"121499","DOI":"10.1016\/j.lfs.2023.121499","volume":"318","author":"C Bica","year":"2023","unstructured":"Bica C, Tirpe A, Nutu A, Ciocan C, Chira S, Gurzau ES, et al. Emerging roles and mechanisms of semaphorins activity in cancer. Life Sci. 2023;318:121499.","journal-title":"Life Sci"},{"key":"1534_CR17","first-page":"4669","volume":"12","author":"B Hu","year":"2020","unstructured":"Hu B, Ruan Y, Wei F, Qin G, Mo X, Wang X, et al. Identification of three glioblastoma subtypes and a six-gene prognostic risk index based on the expression of growth factors and cytokines. Am J Transl Res. 2020;12:4669\u201382.","journal-title":"Am J Transl Res"},{"key":"1534_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.bjc.6604641","volume":"99","author":"L Karayan-Tapon","year":"2008","unstructured":"Karayan-Tapon L, Wager M, Guilhot J, Levillain P, Marquant C, Clarhaut J, et al. Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker? Br J cancer. 2008;99:1153\u201360.","journal-title":"Br J cancer"},{"key":"1534_CR19","first-page":"269","volume":"28","author":"X Zhou","year":"2012","unstructured":"Zhou X, Ma L, Li J, Gu J, Shi Q, Yu R. Effects of SEMA3G on migration and invasion of glioma cells. Oncol Rep. 2012;28:269\u201375.","journal-title":"Oncol Rep."},{"key":"1534_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.neuron.2018.12.036","volume":"101","author":"C Tan","year":"2019","unstructured":"Tan C, Lu NN, Wang CK, Chen DY, Sun NH, Lyu H, et al. Endothelium-derived semaphorin 3G regulates hippocampal synaptic structure and plasticity via Neuropilin-2\/PlexinA4. Neuron. 2019;101:920\u201337.","journal-title":"Neuron"},{"key":"1534_CR21","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.3390\/ijms24044217","volume":"24","author":"C Cencioni","year":"2023","unstructured":"Cencioni C, Scagnoli F, Spallotta F, Nasi S, Illi B. The \u201cSuperoncogene\u201d Myc at the crossroad between metabolism and gene expression in glioblastoma multiforme. Int J Mol Sci. 2023;24:4217.","journal-title":"Int J Mol Sci"},{"key":"1534_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI135296","volume":"131","author":"DY Chen","year":"2021","unstructured":"Chen DY, Sun NH, Chen X, Gong JJ, Yuan ST, Hu ZZ, et al. Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating \u03b2-catenin-dependent vascular remodeling. J Clin Investig. 2021;131:e135296.","journal-title":"J Clin Investig"},{"key":"1534_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.stem.2018.03.011","volume":"22","author":"X Wang","year":"2018","unstructured":"Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, et al. Reciprocal signaling between glioblastoma stem cells and differentiated tumor cells promotes malignant progression. Cell Stem Cell. 2018;22:514\u201328.","journal-title":"Cell Stem Cell"},{"key":"1534_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347:70\u201378.","journal-title":"J Immunol Methods"},{"key":"1534_CR25","first-page":"4880","volume":"191","author":"AM Griesinger","year":"2013","unstructured":"Griesinger AM, Birks DK, Donson AM, Amani V, Hoffman LM, Waziri A, et al. Characterization of distinct immunophenotypes across pediatric brain tumor types. J Immunol (Balt, Md : 1950). 2013;191:4880\u20138.","journal-title":"J Immunol (Balt, Md : 1950)"},{"key":"1534_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-018-03051-5","volume":"141","author":"BS Kruthika","year":"2019","unstructured":"Kruthika BS, Jain R, Arivazhagan A, Bharath RD, Yasha TC, Kondaiah P, et al. Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma. J neuro-Oncol. 2019;141:315\u201325.","journal-title":"J neuro-Oncol"},{"key":"1534_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2017.09.001","volume":"171","author":"T Isoda","year":"2017","unstructured":"Isoda T, Moore AJ, He Z, Chandra V, Aida M, Denholtz M, et al. Non-coding transcription instructs chromatin folding and compartmentalization to dictate enhancer-promoter communication and T cell fate. Cell. 2017;171:103\u201319.","journal-title":"Cell"},{"key":"1534_CR28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.molcel.2021.01.015","volume":"81","author":"T Huang","year":"2021","unstructured":"Huang T, Yang Y, Song X, Wan X, Wu B, Sastry N, et al. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. Mol cell. 2021;81:1276\u201391.","journal-title":"Mol cell"},{"key":"1534_CR29","volume":"6","author":"Y Xie","year":"2021","unstructured":"Xie Y, He L, Lugano R, Zhang Y, Cao H, He Q, et al. Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing. JCI insight. 2021;6:e150861.","journal-title":"JCI insight"},{"key":"1534_CR30","doi-asserted-by":"publisher","first-page":"D719","DOI":"10.1093\/nar\/gkab962","volume":"50","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, He M, Kong X, Jiang P, Liu X, et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2022;50:D719\u2013D728.","journal-title":"Nucleic Acids Res"},{"key":"1534_CR31","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids Res. 2019;47:D607\u2013D613.","journal-title":"Nucleic acids Res"},{"key":"1534_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2443.2005.00877.x","volume":"10","author":"M Taniguchi","year":"2005","unstructured":"Taniguchi M, Masuda T, Fukaya M, Kataoka H, Mishina M, Yaginuma H, et al. Identification and characterization of a novel member of murine semaphorin family. Genes Cells. 2005;10:785\u201392.","journal-title":"Genes Cells"},{"key":"1534_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/cr.2011.198","volume":"22","author":"A Sakurai","year":"2012","unstructured":"Sakurai A, Do\u00e7i CL, Gutkind JS. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 2012;22:23\u201332.","journal-title":"Cell Res"},{"key":"1534_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2016.08.001","volume":"29","author":"G Neufeld","year":"2016","unstructured":"Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, et al. The semaphorins and their receptors as modulators of tumor progression. Drug Resistance Updates. 2016;29:1\u201312.","journal-title":"Drug Resistance Updates"},{"key":"1534_CR35","first-page":"e2201436","volume":"9","author":"EA Adjei-Sowah","year":"2022","unstructured":"Adjei-Sowah EA, O\u2019Connor SA, Veldhuizen J, Lo Cascio C, Plaisier C, Mehta S, et al. Investigating the interactions of glioma stem cells in the perivascular niche at single-cell resolution using a microfluidic tumor microenvironment model. Adv Sci (Weinh, Baden-Wurtt, Ger). 2022;9:e2201436.","journal-title":"Adv Sci (Weinh, Baden-Wurtt, Ger)"},{"key":"1534_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s43018-020-00147-8","volume":"2","author":"W Ma","year":"2021","unstructured":"Ma W, Wang Y, Zhang R, Yang F, Zhang D, Huang M, et al. Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma. Nat cancer. 2021;2:83\u201397.","journal-title":"Nat cancer"},{"key":"1534_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005583","volume":"11","author":"X Dong","year":"2023","unstructured":"Dong X, Ren J, Amoozgar Z, Lee S, Datta M, Roberge S, et al. Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice. J Immunother cancer. 2023;11:e005583.","journal-title":"J Immunother cancer"},{"key":"1534_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018;15:325\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"1534_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","volume":"11","author":"C Calabrese","year":"2007","unstructured":"Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11:69\u201382.","journal-title":"Cancer Cell"},{"key":"1534_CR40","doi-asserted-by":"publisher","first-page":"27230","DOI":"10.1074\/jbc.M804520200","volume":"283","author":"A Shimizu","year":"2008","unstructured":"Shimizu A, Mammoto A, Italiano JE Jr., Pravda E, Dudley AC, Ingber DE, et al. ABL2\/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. J Biol Chem. 2008;283:27230\u20138.","journal-title":"J Biol Chem"},{"key":"1534_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07694-4","volume":"20","author":"DMO Higgins","year":"2020","unstructured":"Higgins DMO, Caliva M, Schroeder M, Carlson B, Upadhyayula PS, Milligan BD, et al. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas. BMC cancer. 2020;20:1213.","journal-title":"BMC cancer"},{"key":"1534_CR42","doi-asserted-by":"publisher","first-page":"57851","DOI":"10.18632\/oncotarget.11072","volume":"7","author":"L Jacob","year":"2016","unstructured":"Jacob L, Sawma P, Garnier N, Meyer LA, Fritz J, Hussenet T, et al. Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide. Oncotarget. 2016;7:57851\u201365.","journal-title":"Oncotarget"},{"key":"1534_CR43","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.7150\/thno.50613","volume":"11","author":"C Zhong","year":"2021","unstructured":"Zhong C, Tao B, Tang F, Yang X, Peng T, You J, et al. Remodeling cancer stemness by collagen\/fibronectin via the AKT and CDC42 signaling pathway crosstalk in glioma. Theranostics. 2021;11:1991\u20132005.","journal-title":"Theranostics"},{"key":"1534_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217059","volume":"597","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Zhou Y, Lv P, Zhou T, Liu H, Xie Y, et al. NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization. Cancer Lett. 2024;597:217059.","journal-title":"Cancer Lett"},{"key":"1534_CR45","doi-asserted-by":"publisher","first-page":"101257","DOI":"10.1016\/j.mam.2024.101257","volume":"96","author":"S You","year":"2024","unstructured":"You S, Xu J, Guo Y, Guo X, Zhang Y, Zhang N, et al. E3 ubiquitin ligase WWP2 as a promising therapeutic target for diverse human diseases. Mol Asp Med. 2024;96:101257.","journal-title":"Mol Asp Med"},{"key":"1534_CR46","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2008.04.043","volume":"133","author":"X Chen","year":"2008","unstructured":"Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 2008;133:1106\u201317.","journal-title":"Cell"},{"key":"1534_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00039.2017","volume":"99","author":"P Karagiannis","year":"2019","unstructured":"Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, et al. Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev. 2019;99:79\u2013114.","journal-title":"Physiol Rev"},{"key":"1534_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"1534_CR49","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1158\/0008-5472.CAN-22-1247","volume":"82","author":"LP Loevenich","year":"2022","unstructured":"Loevenich LP, Tschurtschenthaler M, Rokavec M, Silva MG, Jesinghaus M, Kirchner T, et al. SMAD4 loss induces c-MYC-mediated NLE1 upregulation to support protein biosynthesis, colorectal cancer growth, and metastasis. Cancer Res. 2022;82:4604\u201323.","journal-title":"Cancer Res"},{"key":"1534_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41418-020-00703-w","volume":"28","author":"RB Damgaard","year":"2021","unstructured":"Damgaard RB. The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities. Cell Death Differ. 2021;28:423\u20136.","journal-title":"Cell Death Differ"},{"key":"1534_CR51","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","volume":"25","author":"JM Tsai","year":"2024","unstructured":"Tsai JM, Nowak RP, Ebert BL, Fischer ES. Targeted protein degradation: from mechanisms to clinic. Nat Rev Mol Cell Biol. 2024;25:740\u201357.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1534_CR52","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/cdd.2016.151","volume":"24","author":"EJ Kim","year":"2017","unstructured":"Kim EJ, Kim SH, Jin X, Jin X, Kim H. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc. Cell Death Differ. 2017;24:649\u201359.","journal-title":"Cell Death Differ"},{"key":"1534_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1084\/jem.20151673","volume":"214","author":"X Fang","year":"2017","unstructured":"Fang X, Zhou W, Wu Q, Huang Z, Shi Y, Yang K, et al. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination. J Exp Med. 2017;214:245\u201367.","journal-title":"J Exp Med"},{"key":"1534_CR54","doi-asserted-by":"publisher","first-page":"189140","DOI":"10.1016\/j.bbcan.2024.189140","volume":"1879","author":"Y Qi","year":"2024","unstructured":"Qi Y, Rezaeian AH, Wang J, Huang D, Chen H, Inuzuka H, et al. Molecular insights and clinical implications for the tumor suppressor role of SCF(FBXW7) E3 ubiquitin ligase. Biochimica et Biophysica Acta Rev Cancer. 2024;1879:189140.","journal-title":"Biochimica et Biophysica Acta Rev Cancer"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01534-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:02:50Z","timestamp":1764604970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01534-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1534"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01534-3","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed in accordance with NIH and relevant guidelines for the care and use of laboratory animals of Nanjing Medical University in China, and approved by the Institutional Animal Care and Use Committee at Nanjing Medical University (IACUC-1912036). Human samples were obtained with informed consent of patients, and all experimental procedures were performed in accordance with the recognized ethical guidelines of the Declaration of Helsinki (2013), and approved by the Ethics Committee of the Third Affiliated Hospital of Nanjing Medical University ([2024]KY034-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}